Electronic inhaler

1. An electronic inhaler comprising: a housing having a first end and a second end and defining a first medication passageway and a second medication passageway, the housing having an aperture at the first end and a homogenizing area at the second end and an internal passageway beginning at the aperture and terminating into the homogenizing area, the first medication passageway having a first end and a second end with the second end of the first medication passageway terminating into the homogenizing area and the second medication passageway having a first end and a second end with the second end of the second medication passageway terminating into the homogenizing area, a first end portion of the first medication passageway defining a first cartridge compartment and a first end portion of the second medication passageway defining a second cartridge compartment; a first measuring reservoir compartment (“first MRC”) disposed within an intermediate portion of the first medication passageway or defined by the intermediate portion of the first medication passageway; a second measuring reservoir compartment (“second MRC”) disposed within an intermediate portion of the second medication passageway or defined by the intermediate portion of the second medication passageway; a first launch pad (“first LP) disposed at the second end of the first medication passageway, the first LP having an exit end in communication with the homogenizing area; a second launch pad (“second LP”) disposed at the second end of the second medication passageway, the second LP having an exit end in communication with the homogenizing area; a microcontroller secured internally or externally to the housing for controlling operation of the electronic inhaler; wherein the first cartridge compartment is adapted for receipt of a first cartridge and the second cartridge compartment is adapted for receipt of a second cartridge; a first valve for controlling communication between the first MRC and the first cartridge when the first cartridge is disposed within the first cartridge component; a second valve for controlling communication between the second MRC and the second cartridge when the second cartridge is disposed within the second cartridge compartment; a third valve for controlling communication between the first MRC and the first LP and a fourth valve for controlling communication between the second MRC and the second LP.

2. The electronic inhaler of claim 1 wherein the microcontroller is configured to receive a medication or dosing schedule for a patient and controls a time of administering and an amount of medication dispensed through the first medication passageway or the second medication passageway based on the medication or dosing schedule.

3. The electronic inhaler of claim 1 further comprising a mouthpiece disposed at the second end of the housing, wherein the mouthpiece surrounds the homogenizing area when the mouthpiece is secured at the second end of the internal passageway.

4. The electronic inhaler of claim 3 wherein the mouthpiece is permanently secured to the housing.

5. The electronic inhaler of claim 3 wherein the mouthpiece is removably secured to the housing.

6. The electronic inhaler of claim 1 wherein the microcontroller is programmed to cause the first valve to be in an open position for a specific amount of time to permit a precise amount of content to flow from the first cartridge into the first MRC or to cause the second valve to be in an open position for a specific amount of time to permit a precise amount of content to flow from the second cartridge into the second MRC.

7. The electronic inhaler of claim 6 wherein the content from the first cartridge that the first cartridge compartment is configured to receive is a liquid medication and the content from the second cartridge that the second cartridge compartment is configured to receive is a dry powder medication.

8. The electronic inhaler of claim 3 wherein in use upon inhalation by a user air entering through the housing aperture and flowing through the internal passageway and received within the homogenizing area interacts with an amount of medication received into the homogenizing area from either the first LP or the second LP to create a torsional vortex.

9. The electronic inhaler of claim 3 further comprising one or more sensors disposed within the mouthpiece and in communication with the microcontroller to inform the microcontroller when a user inhales using the electronic inhaler.

10. The electronic inhaler of claim 1 wherein the microcontroller is programmed to cause either the third valve to be in an open position for a specific amount of time to permit a precise amount of content contained with the first MRC to flow to the first LP or to cause the fourth valve to be in an open position for a specific amount of time to permit a precise amount of content contained with the second MRC to flow to the second LP.

11. The electronic inhaler of claim 1 further comprising a first cartridge data reader disposed within the first cartridge compartment and a second cartridge data reader disposed within the second cartridge compartment.

12. An electronic inhaler comprising: a housing having a first end and a second end and defining a first medication passageway and a second medication passageway, the housing having an aperture at the first end and a homogenizing area at the second end and an internal passageway beginning at the aperture and terminating into the homogenizing area, the first medication passageway having a first end and a second end with the second end of the first medication passageway terminating into the homogenizing area and the second medication passageway having a first end and a second end with the second end of the second medication passageway terminating into the homogenizing area, a first end portion of the first medication passageway defining a first cartridge compartment and a first end portion of the second medication passageway defining a second cartridge compartment; a first measuring reservoir compartment (“first MRC”) disposed within an intermediate portion of the first medication passageway or defined by the intermediate portion of the first medication passageway; a second measuring reservoir compartment (“second MRC”) disposed within an intermediate portion of the second medication passageway or defined by the intermediate portion of the second medication passageway; a first launch pad (“first LP) disposed at the second end of the first medication passageway, the first LP having an exit end in communication with the homogenizing area; a second launch pad (“second LP”) disposed at the second end of the second medication passageway, the second LP having an exit end in communication with the homogenizing area; a microcontroller secured internally or externally to the housing for controlling operation of the electronic inhaler; wherein the first cartridge compartment is adapted for receipt of a first cartridge and the second cartridge compartment is adapted for receipt of a second cartridge; a first barrier disposed within the homogenizing area in proximity to an exit end of the first LP and a second barrier disposed within the homogenizing area in proximity to an exit end of the second LP and a first wall disposed within the homogenizing area and a second wall disposed within the homogenizing area; the first barrier and the first wall defining a first substantially circular or oval shaped medication travel path and the second barrier and the second wall defining a second substantially circular or oval shaped medication travel path; the first wall and the second wall defining an exit aperture; wherein in use medication leaving the first LP travels through the first medication travel path before exiting the homogenizing area through the exit aperture or medication leaving the second LP travels through the second medication travel path before exiting the homogenizing area through the exit aperture.

13. An electronic inhaler comprising: a housing having a first end and a second end and defining a first medication passageway and a second medication passageway, the housing having an aperture at the first end and a homogenizing area at the second end and an internal passageway beginning at the aperture and terminating into the homogenizing area, the first medication passageway having a first end and a second end with the second end of the first medication passageway terminating into the homogenizing area and the second medication passageway having a first end and a second end with the second end of the second medication passageway terminating into the homogenizing area, a first end portion of the first medication passageway defining a first cartridge compartment and a first end portion of the second medication passageway defining a second cartridge compartment; a first measuring reservoir compartment (“first MRC”) disposed within an intermediate portion of the first medication passageway or defined by the intermediate portion of the first medication passageway; a second measuring reservoir compartment (“second MRC”) disposed within an intermediate portion of the second medication passageway or defined by the intermediate portion of the second medication passageway; a first launch pad (“first LP) disposed at the second end of the first medication passageway, the first LP having an exit end in communication with the homogenizing area; a second launch pad (“second LP”) disposed at the second end of the second medication passageway, the second LP having an exit end in communication with the homogenizing area; and a microcontroller secured internally or externally to the housing for controlling operation of the electronic inhaler; wherein the first cartridge compartment is adapted for receipt of a first cartridge and the second cartridge compartment is adapted for receipt of a second cartridge; wherein an internal diameter of the first LP is greater in size at a first inlet end of the first LP as compared to a second exit end of the first LP and an internal diameter of the second LP is smaller in size at a first inlet end of the second LP as compared to a second exit end of the second LP.

14. An electronic inhaler comprising: a housing having a first end and a second end and defining a first medication passageway and a second medication passageway, the housing having an aperture at the first end and a homogenizing area at the second end and an internal passageway beginning at the aperture and terminating into the homogenizing area, the first medication passageway having a first end and a second end with the second end of the first medication passageway terminating into the homogenizing area and the second medication passageway having a first end and a second end with the second end of the second medication passageway terminating into the homogenizing area, a first end portion of the first medication passageway defining a first cartridge compartment and a first end portion of the second medication passageway defining a second cartridge compartment; a first measuring reservoir compartment (“first MRC”) disposed within an intermediate portion of the first medication passageway or defined by the intermediate portion of the first medication passageway; a second measuring reservoir compartment (“second MRC”) disposed within an intermediate portion of the second medication passageway or defined by the intermediate portion of the second medication passageway; a first launch pad (“first LP) disposed at the second end of the first medication passageway, the first LP having an exit end in communication with the homogenizing area; a second launch pad (“second LP”) disposed at the second end of the second medication passageway, the second LP having an exit end in communication with the homogenizing area; a microcontroller secured internally or externally to the housing for controlling operation of the electronic inhaler; wherein the first cartridge compartment is adapted for receipt of a first cartridge and the second cartridge compartment is adapted for receipt of a second cartridge; and means for moving the second LP toward the second MRC when an amount of content is contained within the second MRC.

15. The electronic inhaler of claim 14 wherein the means for moving comprises an electromagnet disposed within the housing and in communication with the microcontroller; wherein the microcontroller is programmed to activate the electromagnet when the amount of content is contained within the second MRC, wherein the electromagnet is configured to create a pulling force on a spring secured to the second LP or directly on the second LP where the second LP is at least partially constructed from a magnetic material to cause the second LP to move inward toward the second MRC.

16. An electronic inhaler comprising: a housing having a first end and a second end and defining a first medication passageway and a second medication passageway, the housing having an aperture at the first end and a homogenizing area at the second end and an internal passageway beginning at the aperture and terminating into the homogenizing area, the first medication passageway having a first end and a second end with the second end of the first medication passageway terminating into the homogenizing area and the second medication passageway having a first end and a second end with the second end of the second medication passageway terminating into the homogenizing area, a first end portion of the first medication passageway defining a first cartridge compartment and a first end portion of the second medication passageway defining a second cartridge compartment; a first measuring reservoir compartment (“first MRC”) disposed within an intermediate portion of the first medication passageway or defined by the intermediate portion of the first medication passageway; a second measuring reservoir compartment (“second MRC”) disposed within an intermediate portion of the second medication passageway or defined by the intermediate portion of the second medication passageway; a first launch pad (“first LP) disposed at the second end of the first medication passageway, the first LP having an exit end in communication with the homogenizing area; a second launch pad (“second LP”) disposed at the second end of the second medication passageway, the second LP having an exit end in communication with the homogenizing area; a microcontroller secured internally or externally to the housing for controlling operation of the electronic inhaler; a mouthpiece disposed at the second end of the housing, wherein the mouthpiece surrounds the homogenizing area when the mouthpiece is secured at the second end of the internal passageway; a first valve for controlling communication between the first MRC and the first cartridge when the first cartridge is disposed within the first cartridge component and a second valve for controlling communication between the second MRC and the second cartridge when the second cartridge is disposed within the second cartridge compartment; a third valve for controlling communication between the first MRC and the first LP and a fourth valve for controlling communication between the second MRC and the second LP; wherein the first cartridge compartment is adapted for receipt of a first cartridge and the second cartridge compartment is adapted for receipt of a second cartridge; one or more sensors disposed within the mouthpiece and in communication with the microcontroller to inform the microcontroller when a user inhales using the electronic inhaler; and a first cartridge data reader disposed within the first cartridge compartment and a second cartridge data reader disposed within the second cartridge compartment; wherein the microcontroller is configured to receive a medication or dosing schedule for a patient and controls a time of administering and an amount of medication dispensed through the first medication passageway or the second medication passageway based on the medication or dosing schedule; wherein the microcontroller is programmed to cause the first valve to be in an open position for a specific amount of time to permit a precise amount of content to flow from the first cartridge into the first MRC or to cause the second valve to be in an open position for a specific amount of time to permit a precise amount of content to flow from the second cartridge into the second MRC; wherein the microcontroller is programmed to cause either the third valve to be in an open position for a specific amount of time to permit a precise amount of content contained with the first MRC to flow to the first LP or to cause the fourth valve to be in an open position for a specific amount of time to permit a precise amount of content contained with the second MRC to flow to the second LP.

17. The electronic inhaler of claim 16 wherein the content from the first cartridge that the first cartridge compartment is configured to receive is a liquid medication and the content from the second cartridge that the second cartridge compartment is configured to receive is a dry powder medication.

18. The electronic inhaler of claim 16 wherein in use upon inhalation by a user air entering through the housing aperture and flowing through the internal passageway and received within the homogenizing area interacts with an amount of medication received into the homogenizing area from either the first LP or the second LP to create a torsional vortex.

19. The electronic inhaler of claim 16 further comprising a first barrier disposed within the homogenizing area in proximity to an exit end of the first LP and a second barrier disposed within the homogenizing area in proximity to an exit end of the second LP and a first wall disposed within the homogenizing area and a second wall disposed within the homogenizing area; the first barrier and the first wall defining a first substantially circular or oval shaped medication travel path and the second barrier and the second wall defining a second substantially circular or oval shaped medication travel path; the first wall and the second wall defining an exit aperture; wherein in use medication leaving the first LP travels through the first medication travel path before exiting the homogenizing area through the exit aperture or medication leaving the second LP travels through the second medication travel path before exiting the homogenizing area through the exit aperture.

20. The electronic inhaler of claim 16 wherein an internal diameter of the first LP is greater in size at a first inlet end of the first LP as compared to a second exit end of the first LP and an internal diameter of the second LP is smaller in size at a first inlet end of the second LP as compared to a second exit end of the second LP.

21. The electronic inhaler of claim 16 further comprising means for moving the second LP toward the second MRC when an amount of content is contained within the second MRC.

22. The electronic inhaler of claim 21 wherein the means for moving comprises an electromagnet disposed within the housing and in communication with the microcontroller; wherein the microcontroller is programmed to activate the electromagnet when the amount of content is contained within the second MRC, wherein the electromagnet is configured to create a pulling force on a spring secured to the second LP or directly on the second LP where the second LP is at least partially constructed from a magnetic material to cause the second LP to move inward toward the second MRC.

23. An electronic inhaler comprising: a housing having a first end and a second end and defining a first medication passageway and a second medication passageway, the housing having an aperture at the first end and a homogenizing area at the second end and an internal passageway beginning at the aperture and terminating into the homogenizing area, the first medication passageway having a first end and a second end with the second end of the first medication passageway terminating into the homogenizing area and the second medication passageway having a first end and a second end with the second end of the second medication passageway terminating into the homogenizing area, a first end portion of the first medication passageway defining a first cartridge compartment and a first end portion of the second medication passageway defining a second cartridge compartment; a first measuring reservoir compartment (“first MRC”) disposed within an intermediate portion of the first medication passageway or defined by the intermediate portion of the first medication passageway; a second measuring reservoir compartment (“second MRC”) disposed within an intermediate portion of the second medication passageway or defined by the intermediate portion of the second medication passageway; a first launch pad (“first LP) disposed at the second end of the first medication passageway, the first LP having an exit end in communication with the homogenizing area, an internal diameter of the first LP is greater in size at a first inlet end of the first LP as compared to a second exit end of the first LP; a second launch pad (“second LP”) disposed at the second end of the second medication passageway, the second LP having an exit end in communication with the homogenizing area, an internal diameter of the second LP is smaller in size at a first inlet end of the second LP as compared to a second exit end of the second LP; a microcontroller secured internally or externally to the housing for controlling operation of the electronic inhaler; a mouthpiece disposed at the second end of the housing, wherein the mouthpiece surrounds the homogenizing area when the mouthpiece is secured at the second end of the internal passageway; a first valve for controlling communication between the first MRC and the first cartridge when the first cartridge is disposed within the first cartridge component and a second valve for controlling communication between the second MRC and the second cartridge when the second cartridge is disposed within the second cartridge compartment; a third valve for controlling communication between the first MRC and the first LP and a fourth valve for controlling communication between the second MRC and the second LP; wherein the first cartridge compartment is adapted for receipt of a first cartridge and the second cartridge compartment is adapted for receipt of a second cartridge; one or more sensors disposed within the mouthpiece and in communication with the microcontroller to inform the microcontroller when a user inhales using the electronic inhaler; a first cartridge data reader disposed within the first cartridge compartment and a second cartridge data reader disposed within the second cartridge compartment; and a vibrating apparatus associated with the second medication passageway; wherein the microcontroller is configured to receive a medication or dosing schedule for a patient and controls a time of administering and an amount of medication dispensed through the first medication passageway or the second medication passageway based on the medication or dosing schedule; wherein the microcontroller is programmed to cause the first valve to be in an open position for a specific amount of time to permit a precise amount of content of liquid medication to flow from the first cartridge into the first MRC or to cause the second valve to be in an open position for a specific amount of time to permit a precise amount of content of dry powder medication to flow from the second cartridge into the second MRC; wherein the microcontroller is programmed to cause either the third valve to be in an open position for a specific amount of time to permit a precise amount of content of liquid medication contained with the first MRC to flow to the first LP or to cause the fourth valve to be in an open position for a specific amount of time to permit a precise amount of content of dry powder medication contained with the second MRC to flow to the second LP; wherein in use upon inhalation by a user air entering through the housing aperture and flowing through the internal passageway and received within the homogenizing area interacts with an amount of medication received into the homogenizing area from either the first LP or the second LP to create a torsional vortex.

24. The electronic inhaler of claim 23 further comprising a first barrier disposed within the homogenizing area in proximity to an exit end of the first LP and a second barrier disposed within the homogenizing area in proximity to an exit end of the second LP and a first wall disposed within the homogenizing area and a second wall disposed within the homogenizing area; the first barrier and the first wall defining a first substantially circular or oval shaped medication travel path and the second barrier and the second wall defining a second substantially circular or oval shaped medication travel path; the first wall and the second wall defining an exit aperture; wherein in use medication leaving the first LP travels through the first medication travel path before exiting the homogenizing area through the exit aperture or medication leaving the second LP travels through the second medication travel path before exiting the homogenizing area through the exit aperture.

25. The electronic inhaler of claim 23 further comprising an electromagnet disposed within the housing and in communication with the microcontroller; wherein the microcontroller is programmed to activate the electromagnet when an amount of content is contained within the second MRC, wherein the electromagnet is configure to create a pulling force on a spring secured to the second LP or directly on the second LP where the second LP is at least partially constructed from a magnetic material to cause the second LP to move inward toward the second MRC.